Wellness-education in patients/caregivers with NSCLC treated with icotinib are feasible and could improve patients' QOL and their relationship with caregivers.
No takes yet. Share an insight, caveat, or question.
Li et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: